4 March 2021 - - US-based biopharmaceutical company AmMax Bio, Inc has appointed John Varian as an independent board member, the company said.
Varian brings a wealth of industry experience to the board of AmMax, having held leadership po...
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
4 March 2021 - - Ireland-based specialty pharmaceutical company Shorla Pharma Ltd has named Nicholas Holsman as chief commercial officer, the company said.
Shorla specializes in developing innovative oncology drugs, with a focus on orpha...
Shorla specializes in developing innovative oncology drugs, with a focus on orpha...
4 March 2021 - - US-based microbiome therapeutics platform company Seres Therapeutics, Inc. (NASDAQ: MCRB) has achieved target enrollment of the Phase 2b ECO-RESET clinical study of SER-287 in patients with mild-to-moderate ulcerative colitis in...
4 March 2021 - - Chinese commercial-stage biotechnology company BeiGene, Ltd's (NASDAQ: BGNE) (HKEX: 06160) Brukinsa (zanubrutinib) has been approved by Health Canada for the treatment of adult patients with Waldenström's macroglobulin...
4 March 2021 - Norwegian biopharmaceutical company BerGenBio ASA (OSE:BGBIO) has closed recruitment for a trial that will assess the efficacy and safety of bemcentinib for the treatment of hospitalised COVID-19 patients in South Africa and India, the...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe